Effect of Preoperative Iron Isomaltoside 1000 Administration on Hemoglobin Concentration in Patients Undergoing Transcatheter Aortic Valve Implantation
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 214 participants.
Also called NCT04346004
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 214 participants
- Sponsor
- Registry
-
NCT04346004
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT04346004. Randomized; quadruple masking; primary purpose prevention. Start 2020-04-27 (actual); primary completion 2023-03 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Preoperative Iron Isomaltoside 1000 Administration on Hemoglobin Concentration in Patients Undergoing Transcatheter Aortic Valve Implantation
- Condition
- Aortic Stenosis (Treated With TAVI)
- Intervention (Drug)
- Normal saline
- Intervention (Drug)
- Iron isomaltoside
- Lead sponsor
- Yonsei University
Record details
- Record id
cardio:ct-nct04346004- Content hash
02d4478e1d52f9bfbcf511e61ef83cddd44ef37251324b6040516c569d37fc7c